NCT05247138

Brief Summary

The aim of this retro-prospective Post-Market Clinical Follow-Up (PMCF) study is to collect long term clinical and safety data on root canal obturation after treatment, or retreatment, by BioRootTM RCS. The patients included in the study had received BioRootTM RCS 5 years ago. Participants will be followed prospectively at 5 and 10 years after root canal treatment. Clinical data, radiographic data, adverse events (safety) and device performance will be collected by the dentist from the inclusion visit until the end of the study.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
142

participants targeted

Target at P50-P75 for all trials

Timeline
39mo left

Started Feb 2022

Longer than P75 for all trials

Geographic Reach
1 country

9 active sites

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress57%
Feb 2022Jul 2029

First Submitted

Initial submission to the registry

December 28, 2021

Completed
2 months until next milestone

First Posted

Study publicly available on registry

February 18, 2022

Completed
Same day until next milestone

Study Start

First participant enrolled

February 18, 2022

Completed
3.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 7, 2025

Completed
3.6 years until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2029

Expected
Last Updated

May 6, 2026

Status Verified

April 1, 2026

Enrollment Period

3.7 years

First QC Date

December 28, 2021

Last Update Submit

April 30, 2026

Conditions

Keywords

Root Canal SealerEndodontic Treatment

Outcome Measures

Primary Outcomes (1)

  • Clinical and radiological performance impact of the endodontic treatment at 5 years.

    The "success" and "failure" of the 5-year clinical and radiological performance impact of the endodontic treatment.

    At 5 years post treatment

Secondary Outcomes (7)

  • Clinical and radiological performance impact of the endodontic treatment at 10 years.

    At 10 years post treatment

  • Evaluation of the need of treatment or retreatment at 5 and 10 years.

    At 5 and 10 Years post treatment

  • Assessment of the "tooth functional retention" at 5 and 10 years.

    At 5 and 10 Years post treatment

  • The technical characteristics of the sealer BioRootTM RCS at 5 and 10 years after Root Canal Treatment.

    At 5 and 10 Years post treatment

  • The ease of use and insertion of BioRootTM RCS in the canal.

    At 5 years post treatment

  • +2 more secondary outcomes

Interventions

BioRoot™ RCS is a hydrophilic mineral root canal sealer prepared from the mixture of a powder part and a liquid part. BioRoot™ RCS is a class III implantable medical device. This device is intended to be used in dentistry for permanent obturation of root canals of permanent and mature teeth with adjunction of gutta-percha points. Exposure to the sealer BioRootTM RCS starts from the day when the root canal treatment is performed until the end of individual observational period or the removal of the sealer in case of extraction or retreatment, if this event occurs before the end of individual observational period.

Eligibility Criteria

Age18 Years+
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patient in need of root canal treatment (or retreatment).

You may qualify if:

  • Patient who had a non-surgical root canal treatment with BioRootTM RCS, in a context of an endodontic treatment, or retreatment, 5 years (± 6 months) ago.
  • All roots of the investigational teeth were treated with BioRootTM RCS.
  • Having a documented retro-alveolar radiography immediately after root canal obturation.
  • Patient affiliated or beneficiary of a social security system.
  • Patient has signed his/her informed consent form.

You may not qualify if:

  • History of malignant tumors in the 5 years prior to the root canal treatment.
  • Non-stabilized systemic disease during the month prior to the root canal treatment (diabetes, hypertension, thyroid disorders, etc.).
  • Patient who developed a systemic pathology after the root canal treatment with BioRootTM RCS.
  • The Root canal treatment with BioRootTM RCS is on a wisdom tooth.
  • Tooth presenting an advanced periodontal disease (parodontal pocket ≥ 5mm or bone loss ≥ 50%).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (9)

Cabinet Dentaire

Levallois-Perret, Perret, 92300, France

Location

Cabinet dentaire

Dijon, 21000, France

Location

Cabinet Dentaire

Muizon, 51140, France

Location

Cabinet dentaire

Paris, 75006, France

Location

Cabinet dentaire

Paris, 75009, France

Location

Cabinet dentaire

Plérin, 22190, France

Location

Cabinet dentaire

Saint-Amand-sur-Sèvre, 79700, France

Location

Cabinet dentaire

Sézanne, 51120, France

Location

Cabinet Medical

Villiers-sur-Marne, 94350, France

Location

Study Officials

  • Brigitte Grosgogeat, MD, PhD

    CHU de Lyon, France

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
OTHER
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 28, 2021

First Posted

February 18, 2022

Study Start

February 18, 2022

Primary Completion

November 7, 2025

Study Completion (Estimated)

July 1, 2029

Last Updated

May 6, 2026

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will not share

Locations